We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use 51²è¹Ý, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
How to renew marketing authorisations for products granted through different routes and at different times.
A proactive, collaborative, agile and the first of its kind approach to identifying and addressing the challenges faced by AI as a Medical Device (AIaMD).
Up to £55 million is available through the second phase of the RD&D programme to support the development and demonstration of High Temperature Gas Reactor (HTGR) technology in the UK.
An overview of the recyclability assessment methodology (RAM). Under extended producer responsibility for packaging, large producers must report the recyclability of some packaging materials
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
The AMR RD&D programme aims to demonstrate high temperature gas reactor (HTGR) technology by the early 2030s, in time for potential commercial AMRs to support net zero by 2050.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve 51²è¹Ý, we’d like to know more about your visit today. .